CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GVHD During High-Risk Unrelated HSCT: A First-In-Disease Trial - Kean, L.S.; Langston, A.; Qayed, M.; Khoury, J.; Tiwari, D.; Couture, C.; Renfroe, H.; Sen, S.; Robertson, J.; Waller, E.K.; Horan, J. (Biology of Blood & Marrow Transplantation, 2012)